Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-273517
Filing Date
2024-12-09
Accepted
2024-12-09 17:12:31
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B5 d898543d424b5.htm 424B5 345180
2 EX-FILING FEES d898543dexfilingfees.htm   iXBRL EX-FILING FEES 42978
3 GRAPHIC g898543g1221050339091.jpg GRAPHIC 6621
  Complete submission text file 0001193125-24-273517.txt   527182

Data Files

Seq Description Document Type Size
16 EXTRACTED XBRL INSTANCE DOCUMENT d898543dexfilingfees_htm.xml XML 5394
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269086 | Film No.: 241535974
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)